AV

Alice Vickers

Associate at Forbion

Netherlands

Overview

Work Experience

  • Associate

    2024

  • Analyst

    2023 - 2024

    Forbion invests in life sciences companies that are active in the bio-pharmaceutical space. Forbion manages €3 billion across multiple fund strategies that cover all stages of drug development.

  • Healthcare Investor

    2021 - 2023

    Inkef is a €500M VC fund, backing promising early stage Healthcare and Technology companies in Europe. Board Observer: NMD Pharma, Salvia BioElectronics, Audion Therapeutics

  • Project Advisor

    2020 - 2020

    Syncona is a leading venture capital fund focused on founding, building and funding global leaders in life science.

  • Fellow

    2019 - 2019

    Strategic, corporate venture arm of Merck KGaA.

  • President (formerly Business Development Director)

    2016 - 2019

    The Innovation Forum is an accelerator for healthcare ventures.

  • Marketing & Business Development Executive

    2015 - 2016

  • Research Scientist

    2015 - 2015

    Prof. Mustafa Djamgoz lab.

Relevant Websites